Paasa Logo
OPKO Health, Inc. logo
OPKNASDAQMarket closedOpens 9:30am ET

OPKO Health, Inc.

$1.63Last updated
-$0.01 (0.61%)Past day
Timezone

OPKO Health, Inc. (NASDAQ: OPK) is trading at $1.63, about ₹157 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, down 0.61% today. Indian residents can buy OPKO Health from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$1.64
Previous close:$1.64
Volume:1.61M

Today's low

$1.61

Today's high

$1.64

52 week low

$0.98

52 week high

$1.75

OPK opened at $1.64, closed previously at $1.64, and has traded between $0.98 and $1.75 over the past 52 weeks.

About

OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare. BioReference serves a diverse client base, including medical practices, clinics, hospitals, employers, and government entities. Additionally, this segment provides a cutting-edge diagnostic instrument system designed for immediate, point-of-care blood test results, alongside its specialized 4Kscore testing for prostate cancer. Within the Pharmaceutical segment, OPKO offers a range of therapeutic products and a robust development pipeline. Key offerings include Rayaldee, indicated for the management of secondary hyperparathyroidism in adults suffering from stage 3 or 4 chronic kidney disease and vitamin D insufficiency. The pipeline features OPK88004, an investigational orally administered selective androgen receptor modulator; OPK88003, a peptide administered once weekly currently in Phase IIb trials for the treatment of type 2 diabetes and obesity; and hGH-CTP, a once-weekly human growth hormone injection that has successfully completed Phase III clinical trials in collaboration with Pfizer, Inc. A core strategy for this segment involves the development and commercialization of proprietary, extended-release versions of existing therapeutic proteins. Furthermore, OPKO Health supplies specialty active pharmaceutical ingredients (APIs) and is involved in the development, manufacturing, marketing, and sale of pharmaceutical, nutraceutical, veterinary, and ophthalmic products. The company also commercializes food supplements and over-the-counter products, produces and sells items primarily within the generics market, and handles the import, marketing, distribution, and sales of pharmaceutical products across various therapeutic areas, including cardiovascular conditions, vaccines, antibiotics, gastro-intestinal ailments, and hormone-related treatments, among others. Its pharmaceutical operations are further bolstered by platforms situated in Ireland, Chile, Spain, and Mexico. Founded in 1991, OPKO Health, Inc. maintains its corporate headquarters in Miami, Florida.

Country
US
CEO
Phillip Frost
Exchange listed on
NASDAQ
Industry
Medical - Diagnostics & Research
Base currency
USD
Full Time Employees
2,275
Sector
Healthcare
IPO date
02/11/1995

Key statistics

Avg. volume

3.36M

Market cap

$1.22B

P/E Ratio

-17.10

Price-to-sales ratio

2.07

Enterprise value

$1.31B

Free cash flow yield

-11.02%

Debt-to-equity ratio

0.33

Return on equity

-5.88%

ROIC

-9.07%

Beta

1.50

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$606.88M

Earnings per share

-$0.30

Free cash flow

-$190.82M

Net profit margin

-12.40%

Gross margin

30.98%

EBITDA

-$41.30M

Revenue growth

-14.90%

Similar securities

This is not an investment recommendation

How to buy OPKO Health from India

Indian residents can buy OPKO Health shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for OPKO Health and place an order

    Find OPKO Health by name or by its ticker, OPK, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. OPKO Health trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your OPKO Health position in USD and INR. OPKO Health pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in OPKO Health from India

Trading and taxes when buying OPKO Health from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneOPKO Health does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy OPKO Health stock?

Yes. OPKO Health (OPK) has been listed on NASDAQ since 1995, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one OPKO Health share cost in rupees?

One OPKO Health share is $1.63 — about ₹157 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the OPKO Health price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying OPKO Health from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of OPKO Health?

Yes. One OPKO Health share is $1.63, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in OPKO Health.

How are gains on OPKO Health shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the OPKO Health price. Paasa issues a capital-gains statement for your return.

Does OPKO Health pay a dividend?

No. OPKO Health does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade OPKO Health from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on OPKO Health shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare OPKO Health shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your OPKO Health holding, its cost and its closing value.

How do I sell OPKO Health and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.